Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Income Statement 2020–2022
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 2.3M | 28.3M | 2.9M |
| Gross Profit | 2.3M | 27.9M | 1.7M |
| Profitability | |||
| Operating Income | -23.7M | -39.3M | -55.3M |
| EBITDA | — | — | — |
| Net Income | -28.2M | -54.6M | -80.1M |
| Per Share Data | |||
| EPS (diluted) | $-89.27 | $-1.93 | $-5.43 |
| Shares Outstanding (dil.) | 0M | 28M | 15M |
Elicio Therapeutics Inc. Income Statement — FAQ
Elicio Therapeutics Inc. (ELTX) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELTX's income statement history?
The chart and table above show Elicio Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.